Demonstrating potential of cell therapy for Wilson’s disease with the long-evans cinnamon rat model

Fadi Luc Jaber, Yogeshwar Sharma, Sanjeev Gupta

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

Wilson’s disease (WD) is characterized by the inability to excrete copper (Cu) from the body with progressive tissue injury, especially in liver and brain. The molecular defect in WD concerns mutations in ATP7B gene leading to loss of Cu transport from the hepatocyte to the bile canaliculus. While drugs, e.g., Cu chelators, have been available for several decades, these must be taken lifelong, which can be difficult due to issues of compliance or side effects. Many individuals may require liver transplantation, which can also be difficult due to donor organ shortages. Therefore, achieving permanent cures via cell or gene therapy are of great interest for WD. Cell therapy is feasible because transplanted hepatocytes can integrate in liver parenchyma and restore deficient functions, including transport of Cu into bile. The availability of authentic animal models that recapitulate hepatic WD, especially the Long-Evans Cinnamon (LEC) rat, has advanced cell transplantation research in WD. We describe requirements for cell therapy in animal models with several standardized methods for studies to test or refine cell therapy strategies in WD.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages161-178
Number of pages18
Volume1506
DOIs
StatePublished - 2017

Publication series

NameMethods in Molecular Biology
Volume1506
ISSN (Print)10643745

Fingerprint

Inbred LEC Rats
Hepatolenticular Degeneration
Cell- and Tissue-Based Therapy
Hepatocytes
Liver
Animal Models
Bile Canaliculi
Cell Transplantation
Chelating Agents
Bile
Genetic Therapy
Liver Transplantation
Compliance
Copper
Tissue Donors
Mutation
Wounds and Injuries
Brain

Keywords

  • Biliary transport
  • Cell transplantation
  • Copper
  • Liver injury
  • Regeneration
  • Wilson’s disease

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Jaber, F. L., Sharma, Y., & Gupta, S. (2017). Demonstrating potential of cell therapy for Wilson’s disease with the long-evans cinnamon rat model. In Methods in Molecular Biology (Vol. 1506, pp. 161-178). (Methods in Molecular Biology; Vol. 1506). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-6506-9_11

Demonstrating potential of cell therapy for Wilson’s disease with the long-evans cinnamon rat model. / Jaber, Fadi Luc; Sharma, Yogeshwar; Gupta, Sanjeev.

Methods in Molecular Biology. Vol. 1506 Humana Press Inc., 2017. p. 161-178 (Methods in Molecular Biology; Vol. 1506).

Research output: Chapter in Book/Report/Conference proceedingChapter

Jaber, FL, Sharma, Y & Gupta, S 2017, Demonstrating potential of cell therapy for Wilson’s disease with the long-evans cinnamon rat model. in Methods in Molecular Biology. vol. 1506, Methods in Molecular Biology, vol. 1506, Humana Press Inc., pp. 161-178. https://doi.org/10.1007/978-1-4939-6506-9_11
Jaber FL, Sharma Y, Gupta S. Demonstrating potential of cell therapy for Wilson’s disease with the long-evans cinnamon rat model. In Methods in Molecular Biology. Vol. 1506. Humana Press Inc. 2017. p. 161-178. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-6506-9_11
Jaber, Fadi Luc ; Sharma, Yogeshwar ; Gupta, Sanjeev. / Demonstrating potential of cell therapy for Wilson’s disease with the long-evans cinnamon rat model. Methods in Molecular Biology. Vol. 1506 Humana Press Inc., 2017. pp. 161-178 (Methods in Molecular Biology).
@inbook{30f32a615b0948e587f5704301b708db,
title = "Demonstrating potential of cell therapy for Wilson’s disease with the long-evans cinnamon rat model",
abstract = "Wilson’s disease (WD) is characterized by the inability to excrete copper (Cu) from the body with progressive tissue injury, especially in liver and brain. The molecular defect in WD concerns mutations in ATP7B gene leading to loss of Cu transport from the hepatocyte to the bile canaliculus. While drugs, e.g., Cu chelators, have been available for several decades, these must be taken lifelong, which can be difficult due to issues of compliance or side effects. Many individuals may require liver transplantation, which can also be difficult due to donor organ shortages. Therefore, achieving permanent cures via cell or gene therapy are of great interest for WD. Cell therapy is feasible because transplanted hepatocytes can integrate in liver parenchyma and restore deficient functions, including transport of Cu into bile. The availability of authentic animal models that recapitulate hepatic WD, especially the Long-Evans Cinnamon (LEC) rat, has advanced cell transplantation research in WD. We describe requirements for cell therapy in animal models with several standardized methods for studies to test or refine cell therapy strategies in WD.",
keywords = "Biliary transport, Cell transplantation, Copper, Liver injury, Regeneration, Wilson’s disease",
author = "Jaber, {Fadi Luc} and Yogeshwar Sharma and Sanjeev Gupta",
year = "2017",
doi = "10.1007/978-1-4939-6506-9_11",
language = "English (US)",
volume = "1506",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "161--178",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Demonstrating potential of cell therapy for Wilson’s disease with the long-evans cinnamon rat model

AU - Jaber, Fadi Luc

AU - Sharma, Yogeshwar

AU - Gupta, Sanjeev

PY - 2017

Y1 - 2017

N2 - Wilson’s disease (WD) is characterized by the inability to excrete copper (Cu) from the body with progressive tissue injury, especially in liver and brain. The molecular defect in WD concerns mutations in ATP7B gene leading to loss of Cu transport from the hepatocyte to the bile canaliculus. While drugs, e.g., Cu chelators, have been available for several decades, these must be taken lifelong, which can be difficult due to issues of compliance or side effects. Many individuals may require liver transplantation, which can also be difficult due to donor organ shortages. Therefore, achieving permanent cures via cell or gene therapy are of great interest for WD. Cell therapy is feasible because transplanted hepatocytes can integrate in liver parenchyma and restore deficient functions, including transport of Cu into bile. The availability of authentic animal models that recapitulate hepatic WD, especially the Long-Evans Cinnamon (LEC) rat, has advanced cell transplantation research in WD. We describe requirements for cell therapy in animal models with several standardized methods for studies to test or refine cell therapy strategies in WD.

AB - Wilson’s disease (WD) is characterized by the inability to excrete copper (Cu) from the body with progressive tissue injury, especially in liver and brain. The molecular defect in WD concerns mutations in ATP7B gene leading to loss of Cu transport from the hepatocyte to the bile canaliculus. While drugs, e.g., Cu chelators, have been available for several decades, these must be taken lifelong, which can be difficult due to issues of compliance or side effects. Many individuals may require liver transplantation, which can also be difficult due to donor organ shortages. Therefore, achieving permanent cures via cell or gene therapy are of great interest for WD. Cell therapy is feasible because transplanted hepatocytes can integrate in liver parenchyma and restore deficient functions, including transport of Cu into bile. The availability of authentic animal models that recapitulate hepatic WD, especially the Long-Evans Cinnamon (LEC) rat, has advanced cell transplantation research in WD. We describe requirements for cell therapy in animal models with several standardized methods for studies to test or refine cell therapy strategies in WD.

KW - Biliary transport

KW - Cell transplantation

KW - Copper

KW - Liver injury

KW - Regeneration

KW - Wilson’s disease

UR - http://www.scopus.com/inward/record.url?scp=84995376703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995376703&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-6506-9_11

DO - 10.1007/978-1-4939-6506-9_11

M3 - Chapter

C2 - 27830552

AN - SCOPUS:84995376703

VL - 1506

T3 - Methods in Molecular Biology

SP - 161

EP - 178

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -